Protalix BioTherapeutics, Inc. Share Price TEL AVIV STOCK EXCHANGE
Stocks
PLX
US74365A3095
Pharmaceuticals
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 732.50 ILa | -.--% |
|
+3.29% | +69.68% |
| 05-13 | Protalix BioTherapeutics, Inc., Q1 2026 Earnings Call, May 13, 2026 | |
| 05-13 | Protalix BioTherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| Market Cap | 185M 0 162M 149M 139M 263M 17.68B 267M 1.79B 696M 8.68B 696M 681M 30.08B | P/E 2026 * |
11.8x | P/E 2027 * | 46x |
|---|---|---|---|---|---|
| Enterprise Value | 185M 0 162M 149M 139M 263M 17.68B 267M 1.79B 696M 8.68B 696M 681M 30.08B | EV / Sales 2026 * |
2.37x | EV / Sales 2027 * | 2.74x |
| Free-Float |
96.12% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Protalix BioTherapeutics, Inc.
| Manager | Title | Age | Since |
|---|---|---|---|
Dror Bashan
CEO | Chief Executive Officer | 58 | 29/06/2019 |
Gilad Mamlok
DFI | Director of Finance/CFO | 58 | 23/08/2025 |
Ori Kalid
CTO | Chief Tech/Sci/R&D Officer | - | 31/05/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Amos Bar Shalev
BRD | Director/Board Member | 73 | 30/06/2008 |
Aharon Schwartz
BRD | Director/Board Member | 82 | 31/10/2014 |
Dror Bashan
BRD | Director/Board Member | 58 | 29/06/2019 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | +3.29% | - | - | 185M | |
| -1.14% | -2.43% | +53.72% | +159.07% | 1,070B | |
| -1.41% | +0.32% | +66.23% | +60.48% | 624B | |
| -2.42% | +0.18% | +34.59% | +85.62% | 450B | |
| -0.90% | +0.53% | +31.00% | +25.82% | 328B | |
| +0.77% | +0.61% | +38.83% | +40.32% | 292B | |
| +0.37% | -0.93% | +28.47% | +47.69% | 284B | |
| +2.16% | +4.34% | -25.60% | -38.87% | 217B | |
| -2.06% | +1.63% | +22.87% | +64.34% | 198B | |
| -1.26% | +2.60% | +15.98% | +70.00% | 161B | |
| Average | +0.22% | +1.07% | +29.57% | +57.16% | 402.71B | |
| Weighted average by Cap. | +0.64% | +0.77% | +40.16% | +81.63% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 78.3M 0 68.57M 63.16M 58.63M 111M 7.47B 113M 756M 294M 3.67B 294M 288M 12.71B | 67.56M 0 59.17M 54.5M 50.59M 96.07M 6.44B 97.37M 652M 254M 3.16B 254M 248M 10.97B |
| Net income | 15.72M 0 13.77M 12.68M 11.77M 22.36M 1.5B 22.66M 152M 59.08M 736M 59.04M 57.75M 2.55B | 4.07M 0 3.57M 3.29M 3.05M 5.79M 389M 5.87M 39.33M 15.31M 191M 15.3M 14.96M 661M |
| Net Debt | - | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- PLX Stock
- PLX Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
